Trial intelligence / Profile preview

Etomidate and propofol ratio comparison for anesthesia induction in cardiac valve replacement

ChiCTR2100045072Phase 4Recruiting

Sponsor
Affiliated Hospital of Southwest Medical University
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of etomidate and propofol in Cardiac valve disease (VHD) (4 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Mean arterial pressure, Heart rate and 4 more. Started Apr 2021; status: recruiting.

02

Drugs

etomidatepropofol
03

Conditions

Cardiac valve disease (VHD)

Beyond the preview

Go deeper on ChiCTR2100045072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100045072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call